Archives

FOX REPORTS THIRD QUARTER FISCAL 2026 REVENUE OF $3.99 BILLION, NET INCOME OF $175 MILLION, AND ADJUSTED EBITDA OF $954 MILLION

B NEW YORK, May 11, 2026 /PRNewswire/ — Fox Corporation (Nasdaq: FOXA, FOX) (“FOX” or the “Company”) today reported financial results for the three months… Login to continue reading Login…

Read MoreFOX REPORTS THIRD QUARTER FISCAL 2026 REVENUE OF $3.99 BILLION, NET INCOME OF $175 MILLION, AND ADJUSTED EBITDA OF $954 MILLION

Ruder Finn Appoints Kelley Yoder, Global Head of Health and Life Sciences, Signaling Major Investment in Next Phase of Growth

B Veteran Leader Brings Two Decades of Proven Agency Growth and Innovation Appointment Reinforces the Agency’s Integrated, AI-Driven Healthcare Strategy Across PR, Product Marketing, Digital,… Login to continue reading Login…

Read MoreRuder Finn Appoints Kelley Yoder, Global Head of Health and Life Sciences, Signaling Major Investment in Next Phase of Growth

Apnimed Announces Three Oral Presentations and a Late-breaking Poster at the American Thoracic Society (ATS) 2026 International Conference

B CAMBRIDGE, Mass., May 11, 2026 /PRNewswire/ — Apnimed, Inc., a late stage clinical pharmaceutical company dedicated to the discovery, development, and commercialization of novel oral… Login to continue reading Login…

Read MoreApnimed Announces Three Oral Presentations and a Late-breaking Poster at the American Thoracic Society (ATS) 2026 International Conference

Johnson & Johnson reinforces its leadership in advancing neuropsychiatry with new portfolio and pipeline data at APA and ASCP

B Oral presentations feature CAPLYTA® long-term data assessing relapse risk reduction in schizophrenia and new seltorexant analyses in major depressive disorder (MDD) with insomnia symptoms… Login to continue reading Login…

Read MoreJohnson & Johnson reinforces its leadership in advancing neuropsychiatry with new portfolio and pipeline data at APA and ASCP